Summary

India Genetic Testing Market was valued at USD 69.24 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.89% through 2030. The India Genetic Testing Market is primarily driven by several key factors. Increasing awareness and acceptance of genetic testing among the population for diagnosing various genetic disorders and diseases contribute significantly to market growth. Advancements in technology, such as next-generation sequencing and PCR techniques, have enhanced the accuracy and efficiency of genetic testing, further fueling market expansion. The rising prevalence of chronic diseases and genetic disorders in India has also stimulated the demand for genetic testing services. Government initiatives and investments in healthcare infrastructure, coupled with a growing focus on personalized medicine, are fostering market growth. Overall, these factors collectively drive the India Genetic Testing Market toward sustained progression.
Key Market Drivers
Increasing Awareness and Acceptance
One of the primary drivers of the India Genetic Testing Market is the rising awareness and acceptance of genetic testing among the population. Over the years, there has been a significant increase in public awareness regarding the role of genetic testing in diagnosing various genetic disorders and diseases. This increased awareness has been facilitated by educational campaigns, media coverage, and growing discussions within the medical community about the importance of genetic testing for disease prevention, early diagnosis, and personalized treatment approaches. As people become more knowledgeable about the benefits of genetic testing, they are more likely to seek out these services, thereby driving market growth.
Technological Advancements
Another key driver of the India Genetic Testing Market is the continuous advancements in technology, particularly in the field of molecular biology and genetics. Technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray analysis have revolutionized the landscape of genetic testing, enabling faster, more accurate, and cost-effective testing methods. These technological innovations have expanded the scope of genetic testing, allowing for the simultaneous analysis of multiple genes or genomic regions, which is particularly beneficial for complex genetic disorders. As technology continues to evolve, genetic testing methods are becoming more sophisticated, driving market growth and adoption.
Prevalence of Genetic Disorders
The increasing prevalence of genetic disorders and chronic diseases in India is another significant driver of the genetic testing market. Genetic disorders encompass a wide range of conditions, including rare genetic diseases, hereditary cancers, and chromosomal abnormalities, which collectively contribute to the burden of disease in the population. With the growing incidence of genetic disorders, there is a corresponding increase in the demand for genetic testing services for early detection, risk assessment, and genetic counseling. This prevalence-driven demand for genetic testing is expected to fuel market growth as healthcare providers and policymakers prioritize the management and prevention of genetic diseases.
Government Initiatives and Policies
Government initiatives and policies aimed at promoting healthcare infrastructure and improving access to genetic testing services are also driving the India Genetic Testing Market. In recent years, the Indian government has launched various programs and schemes to enhance healthcare delivery, including initiatives focused on genetic screening, counseling, and testing services. These efforts aim to address the unmet needs of underserved populations, improve healthcare equity, and reduce the burden of genetic diseases in the country. By investing in genetic testing infrastructure and subsidizing testing costs, the government is playing a crucial role in driving market expansion and facilitating wider adoption of genetic testing services across India. For instance, in February 2024, the Genetic Research Centre (GRC) at ICMR's National Institute of Reproductive and Child Health (ICMR-NIRRCH) in Mumbai has achieved a notable milestone by becoming Maharashtra's inaugural government facility to provide complimentary genetic testing and counseling services for rare diseases. Currently, the center attends to referrals originating from municipal corporations, government medical colleges, and hospitals within Mumbai's vicinity, as well as rural communities spanning Maharashtra. In an official statement, the institute emphasized its capacity to deliver comprehensive assistance through genetic counseling and testing to individuals grappling with rare diseases.
Personalized Medicine and Targeted Therapies
The growing focus on personalized medicine and targeted therapies is driving the demand for genetic testing in India. Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle factors, and environmental influences. Genetic testing plays a central role in personalized medicine by providing insights into an individual's genetic predispositions, drug responses, and disease risks, thereby enabling more precise diagnosis and treatment decisions. As healthcare providers increasingly recognize the potential of personalized medicine to improve patient outcomes and reduce healthcare costs, the demand for genetic testing is expected to rise, driving market growth in India.
Key Market Challenges
Cost and Affordability
One of the primary challenges hindering the growth of the India Genetic Testing Market is the cost and affordability of genetic testing services. Despite technological advancements that have led to cost reductions in genetic testing, many tests remain relatively expensive, making them unaffordable for a significant portion of the population, particularly in low- and middle-income segments. The high cost of genetic testing can act as a barrier to access, limiting the uptake of testing services among individuals who may benefit from them. The lack of reimbursement policies and inadequate insurance coverage for genetic testing further exacerbate the affordability issue, placing a financial burden on patients who seek testing out-of-pocket. Addressing the cost and affordability of genetic testing is crucial for ensuring equitable access to testing services and maximizing their public health impact in India.
Limited Access in Rural and Underserved Areas
Access to genetic testing services is disproportionately limited in rural and underserved areas of India, posing a significant challenge to equitable healthcare delivery. The majority of genetic testing facilities are concentrated in urban centers, leaving rural populations with limited access to testing services due to geographical barriers, infrastructure constraints, and healthcare workforce shortages. Lack of awareness, inadequate transportation networks, and socioeconomic disparities further exacerbate the access gap, preventing many individuals from seeking genetic testing or receiving timely follow-up care. Addressing the inequities in access to genetic testing requires a multifaceted approach that includes the expansion of testing infrastructure, telemedicine initiatives, community outreach programs, and targeted interventions to overcome barriers specific to rural and underserved populations. By improving access to genetic testing services, India can ensure that all individuals, regardless of their geographic location or socioeconomic status, have the opportunity to benefit from advances in genomic medicine.
Key Market Trends
Expansion of Healthcare Infrastructure
The expansion of healthcare infrastructure, including the establishment of diagnostic laboratories and genetic counseling centers, is facilitating the growth of the genetic testing market in India. In recent years, there has been a significant increase in the number of healthcare facilities offering genetic testing services across the country, driven by both public and private investments in healthcare infrastructure. This expansion has improved access to genetic testing services for individuals residing in urban as well as rural areas, thereby contributing to market growth. As healthcare infrastructure continues to expand and become more accessible, the demand for genetic testing is expected to increase further, driving market expansion.
Rising Healthcare Expenditure
The rising healthcare expenditure in India is also contributing to the growth of the genetic testing market. As the Indian economy continues to grow and household incomes rise, there is a corresponding increase in healthcare spending by individuals and families. This increase in healthcare expenditure is fueling demand for advanced medical services, including genetic testing, as people prioritize preventive healthcare and early disease detection. The growing availability of health insurance coverage for genetic testing and related services is further driving market growth by making these services more affordable and accessible to a larger segment of the population.
Segmental Insights
Type Insights
Based on the Type, Molecular Testing stands out as the dominant force, showcasing remarkable growth and widespread adoption. Molecular testing encompasses a diverse array of techniques that analyze nucleic acids (DNA and RNA) to detect genetic variations, mutations, and biomarkers associated with various diseases and conditions. This dominance can be attributed to several factors, including technological advancements, clinical utility, and the expanding scope of applications across medical specialties. Molecular testing has revolutionized the field of genetics by offering highly sensitive, specific, and efficient methods for genetic analysis. Techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH) have significantly enhanced the accuracy and throughput of genetic testing, enabling the detection of genetic alterations with unprecedented precision. These technological advancements have expanded the capabilities of molecular testing beyond traditional cytogenetic and biochemical methods, allowing for comprehensive analysis of genetic material at the molecular level.
The clinical utility of molecular testing across a wide range of medical specialties has further propelled its dominance in the India Genetic Testing Market. Molecular testing plays a pivotal role in the diagnosis, prognosis, and management of genetic disorders, infectious diseases, cancer, and pharmacogenomics. In the realm of genetic disorders, molecular testing offers rapid and accurate diagnosis of inherited conditions, such as cystic fibrosis, thalassemia, and Duchenne muscular dystrophy, facilitating early intervention and personalized treatment strategies. In infectious disease diagnostics, molecular testing enables the rapid detection and identification of pathogens, including bacteria, viruses, and parasites, leading to timely initiation of appropriate therapy and infection control measures. In oncology, molecular testing has revolutionized cancer care by guiding targeted therapies, predicting treatment response, and monitoring disease progression through the detection of specific mutations and molecular biomarkers.
Application Insights
Based on Application, Reproductive Cancer Screening emerges as a dominant force, reflecting its critical role in preventive healthcare and disease management. Reproductive cancer screening encompasses a range of genetic tests aimed at assessing an individual's risk of developing hereditary cancers affecting the reproductive organs, such as breast, ovarian, uterine, and prostate cancers. Several factors contribute to the dominance of reproductive cancer screening in the genetic testing landscape, including the high prevalence and mortality rates of reproductive cancers in India, the increasing awareness and emphasis on cancer prevention, and the availability of targeted screening programs and interventions.
Breast cancer, in particular, poses a significant public health challenge in India, with rising incidence rates and a high disease burden among women. Genetic testing for hereditary breast cancer susceptibility genes, such as BRCA1 and BRCA2, plays a crucial role in identifying individuals at increased risk of developing breast and ovarian cancers. These genetic tests enable early detection of pathogenic mutations associated with hereditary breast cancer syndromes, allowing for personalized risk assessment, enhanced surveillance, and preventive measures, such as risk-reducing surgeries or intensified screening protocols. Similarly, ovarian cancer represents another major reproductive cancer burden in India, with limited options for early detection and effective treatment. Genetic testing for hereditary ovarian cancer syndromes, such as Lynch syndrome and hereditary breast and ovarian cancer (HBOC) syndrome, helps identify individuals with an elevated risk of developing ovarian cancer due to inherited genetic mutations. Early identification of high-risk individuals through genetic testing enables targeted interventions, such as risk-reducing surgeries, chemoprevention, or close surveillance with imaging and biomarker monitoring, thereby improving clinical outcomes and reducing cancer-related morbidity and mortality.
Regional Insights
North India is dominating the India Genetic Testing Market over other regions, there are several factors contributing to its prominence and significant presence in the genetic testing landscape. These factors include the concentration of healthcare infrastructure, research institutions, economic development, and population demographics, which collectively contribute to North India's strong position in the genetic testing market.
One of the primary reasons for North India's prominence in the genetic testing market is the concentration of major metropolitan areas and urban centers with robust healthcare infrastructure. The National Capital Region (NCR), comprising cities like Delhi, Gurugram, Noida, and Ghaziabad, serves as a hub for healthcare services, research, and innovation. Delhi, as the capital city, is home to premier medical institutions, government hospitals, and research centers, driving advancements in medical genetics and genetic testing services. The presence of leading hospitals, diagnostic laboratories, and academic medical centers in Delhi and its surrounding areas facilitates access to genetic testing services for a large population base. Delhi, located in the southwestern part of the NCR, has emerged as a key player in the genetic testing market, owing to its rapid economic growth and development. The city is home to a burgeoning healthcare sector, with state-of-the-art hospitals, specialty clinics, and diagnostic centers offering advanced genetic testing services. Delhi's strategic location and connectivity to other parts of India and the world make it an attractive destination for healthcare investments and collaborations, further bolstering its position in the genetic testing market.
Key Market Players
• MedGenome Labs Limited
• Strand Life Sciences Pvt Ltd.
• Centogene India Private Limited
• Eurofins Genomics India Pvt Ltd.
• Mapmygenome India Limited
• Clevergene Biocorp Private Limited
• LifeCell International Pvt. Ltd.
• Genes2Me Pvt. Ltd.
• GeneTech India Private Limited
• DNA Forensics Laboratory Pvt. Ltd.
Report Scope:
In this report, the India Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• India Genetic Testing Market, By Type:
o Cytogenetic Testing
o Biochemical Testing
o Molecular Testing
• India Genetic Testing Market, By Application:
o Reproductive Cancer Screening
o Ancestry Testing
o Predictive and Pre-symptomatic Testing
o Others
• India Genetic Testing Market, By Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India Genetic Testing Market.
Available Customizations:
India Genetic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. India Genetic Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Cytogenetic Testing, Biochemical Testing, Molecular Testing)
5.2.2. By Application (Reproductive Cancer Screening, Ancestry Testing, Predictive and Pre-symptomatic Testing, Others)
5.2.3. By Region
5.2.3.1. By State (Top 3 States)
5.2.4. By Company (2024)
5.3. Market Map
6. North India Genetic Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
7. West India Genetic Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
8. South India Genetic Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
9. East India Genetic Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. India Genetic Testing Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. MedGenome Labs Limited
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Strand Life Sciences Pvt Ltd.
14.3. Centogene India Private Limited
14.4. Eurofins Genomics India Pvt Ltd.
14.5. Mapmygenome India Limited
14.6. Clevergene Biocorp Private Limited
14.7. LifeCell International Pvt. Ltd.
14.8. Genes2Me Pvt. Ltd.
14.9. GeneTech India Private Limited
14.10. DNA Forensics Laboratory Pvt. Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer